RAP
Click for more information
0.00% 20.5¢ resapp health limited

“In recent months we have devoted key resources to our pivotal...

  1. minky123
    24 Posts.
    lightbulb Created with Sketch. 6
    clock Created with Sketch.
    09/12/16
    09:55
    Post #: 21219551
    “In recent months we have devoted key resources to our pivotal US paediatric clinical study to ensure that it commenced during the onset of winter and we are very pleased to announce that our first patients have been enrolled on schedule,” said Tony Keating, CEO and Managing Director of ResApp Health.
    RAP Price at posting: 34.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
HAR Haranga resource upgrade builds confidence in Saraya uranium project
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.